Iuchi, Hiroyuki
Sakamoto, Masaya
Matsutani, Daisuke
Suzuki, Hirofumi
Kayama, Yosuke
Takeda, Norihiko
Minamisawa, Susumu
Utsunomiya, Kazunori
Article History
Received: 4 November 2016
Accepted: 4 September 2017
First Online: 19 September 2017
Competing Interests
: This study was funded by Astellas Pharma Inc., Tokyo, Japan. The authors of this manuscript have the following competing interests: MS has participated in speaker’s bureaus/advisory panels for Sanofi, Daiichi-Sankyo, Astellas, and Tanabe-Mitsubishi. NT has received a research grant and support from Daiichi-Sankyo and Otsuka Pharmaceutical and has participated in speaker’s bureaus organised by Daiichi-Sankyo and MSD. KU has received research support from Terumo, Kowa, Taisho, Arkray, Kyowa Kirin, MSD, Astellas, Boehringer Ingelheim, Ono, Novo Nordisk, Kissei and Tanabe-Mitsubishi and has participated in speaker’s bureau/advisory panels for Astellas, Astra Zeneca, Kowa, MSD, Eli Lilly, Taisho, Novo Nordisk and Sanofi. The other authors have no conflict of interest to declare.